Literature DB >> 21473642

A comprehensive compositional analysis of heparin/heparan sulfate-derived disaccharides from human serum.

Wei Wei1, Milady R Niñonuevo, Anish Sharma, Lieza M Danan-Leon, Julie A Leary.   

Abstract

The analysis of heparan sulfate glycosaminoglycans (HSGAGs) variations in human serum at the disaccharide level has a great potential for disease diagnosis and prognosis. However, the lack of available analytical methodology for the compositional analysis of HSGAGs in human serum remains to be addressed to delineate the possible role of HSGAGs on the onset and/or progression of a disease. In this study, we have developed a method for the in-depth compositional analysis of the 12 heparin/HS-derived disaccharides from human serum using a combination of technologies--fractionation, exhaustive digestion, solid phase extraction, and LC-MS/MS. The method exhibits high recovery (72-110%) and good reproducibility (standard deviation of less than 5%) with a low limit of detection and quantification. Errors from the method validation were within 1.1%. Nondetectable non- or low-sulfated disaccharides in human serum were also detected using the optimized protocol. Further applying this method, the comprehensive analysis of HSGAGs compositions in human sera from female donors showed considerable variations in disaccharide patterns and compositions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21473642      PMCID: PMC3094484          DOI: 10.1021/ac2001077

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  40 in total

1.  Integral glycan sequencing of heparan sulfate and heparin saccharides.

Authors:  J E Turnbull
Journal:  Methods Mol Biol       Date:  2001

2.  Total flavonoids quantification from O/W emulsion with extract of Brazilian plants.

Authors:  André Rolim; Tânia Oishi; Carolina P M Maciel; Vivian Zague; Claudinéia A S O Pinto; Telma M Kaneko; Vladi O Consiglieri; Maria Valéria R Velasco
Journal:  Int J Pharm       Date:  2006-02-03       Impact factor: 5.875

3.  Alterations of glycosaminoglycan metabolism in the development of diabetic complications in relation to metabolic control.

Authors:  Katarzyna Komosińska-Vassev; Krystyna Olczyk; Ewa M Koźma; Paweł Olczyk; Grzegorz Wisowski; Katarzyna Winsz-Szczotka
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

4.  Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.

Authors:  P J Wilson; C P Morris; D S Anson; T Occhiodoro; J Bielicki; P R Clements; J J Hopwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 5.  Analysis of glycosaminoglycan-derived disaccharides in biologic samples by capillary electrophoresis and protocol for sequencing glycosaminoglycans.

Authors:  F N Lamari; M Militsopoulou; T N Mitropoulou; A Hjerpe; N K Karamanos
Journal:  Biomed Chromatogr       Date:  2002-04       Impact factor: 1.902

6.  Distinct effects on heparan sulfate structure by different active site mutations in NDST-1.

Authors:  Jenny Bengtsson; Inger Eriksson; Lena Kjellén
Journal:  Biochemistry       Date:  2003-02-25       Impact factor: 3.162

7.  Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.

Authors:  Roger Lawrence; Sara K Olson; Robert E Steele; Lianchun Wang; Rahul Warrior; Richard D Cummings; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

8.  Compositional analysis and quantification of heparin and heparan sulfate by electrospray ionization ion trap mass spectrometry.

Authors:  Ola M Saad; Julie A Leary
Journal:  Anal Chem       Date:  2003-07-01       Impact factor: 6.986

9.  Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate.

Authors:  Noel M Carter; Simi Ali; John A Kirby
Journal:  J Cell Sci       Date:  2003-07-22       Impact factor: 5.285

10.  Graphitized carbon LC-MS characterization of the chondroitin sulfate oligosaccharides of aggrecan.

Authors:  Ruby P Estrella; John M Whitelock; Nicolle H Packer; Niclas G Karlsson
Journal:  Anal Chem       Date:  2007-04-06       Impact factor: 6.986

View more
  24 in total

1.  LC-MS(n) analysis of isomeric chondroitin sulfate oligosaccharides using a chemical derivatization strategy.

Authors:  Rongrong Huang; Vitor H Pomin; Joshua S Sharp
Journal:  J Am Soc Mass Spectrom       Date:  2011-06-23       Impact factor: 3.109

2.  Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach.

Authors:  Yongmei Xu; Zhen Wang; Renpeng Liu; Arlene S Bridges; Xuefei Huang; Jian Liu
Journal:  Glycobiology       Date:  2011-08-11       Impact factor: 4.313

3.  An approach for separation and complete structural sequencing of heparin/heparan sulfate-like oligosaccharides.

Authors:  Rongrong Huang; Jian Liu; Joshua S Sharp
Journal:  Anal Chem       Date:  2013-05-28       Impact factor: 6.986

4.  Method development and analysis of free HS and HS in proteoglycans from pre- and postmenopausal women: evidence for biosynthetic pathway changes in sulfotransferase and sulfatase enzymes.

Authors:  Wei Wei; Rebecca L Miller; Julie A Leary
Journal:  Anal Chem       Date:  2013-05-28       Impact factor: 6.986

5.  Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.

Authors:  Francyne Kubaski; Yasuyuki Suzuki; Kenji Orii; Roberto Giugliani; Heather J Church; Robert W Mason; Vũ Chí Dũng; Can Thi Bich Ngoc; Seiji Yamaguchi; Hironori Kobayashi; Katta M Girisha; Toshiyuki Fukao; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2016-12-22       Impact factor: 4.797

6.  Heparan sulfate differences in rheumatoid arthritis versus healthy sera.

Authors:  Jenny K Sabol; Wei Wei; Marcos López-Hoyos; Youjin Seo; Armann Andaya; Julie A Leary
Journal:  Matrix Biol       Date:  2014-09-11       Impact factor: 11.583

7.  Evaluation of non-reducing end pathologic glycosaminoglycan detection method for monitoring therapeutic response to enzyme replacement therapy in human mucopolysaccharidosis I.

Authors:  Moin U Vera; Steven Q Le; Alla Victoroff; Merry B Passage; Jillian R Brown; Brett E Crawford; Lynda E Polgreen; Agnes H Chen; Patricia I Dickson
Journal:  Mol Genet Metab       Date:  2019-09-11       Impact factor: 4.797

8.  Improved de novo sequencing of heparin/heparan sulfate oligosaccharides by propionylation of sites of sulfation.

Authors:  Quntao Liang; Pradeep Chopra; Geert-Jan Boons; Joshua S Sharp
Journal:  Carbohydr Res       Date:  2018-06-08       Impact factor: 2.104

9.  Quantification of neutral human milk oligosaccharides by graphitic carbon high-performance liquid chromatography with tandem mass spectrometry.

Authors:  Yuanwu Bao; Ceng Chen; David S Newburg
Journal:  Anal Biochem       Date:  2012-10-12       Impact factor: 3.365

10.  Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans.

Authors:  Jon C Gonzales; Philip L S M Gordts; Erin M Foley; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2013-05-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.